O-Methylisourea hydrogen sulfate

pharmaceutical synthetic intermediate

3,6-dibromo-2-methylpyridine

pharmaceutical synthetic intermediate

Benzoic acid, 3-[[(2,6-difluorophenyl)sulfonyl]amino]-2-fluoro-, methyl ester

pharmaceutical intermediate

N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide

Pharmaceutical intermediate compound

Erythromycin, 6-O-methyl-2',4''-bis-O-(trimethylsilyl)-, 9-[O-(1-ethoxy-1-methylethyl)oxime]

Pharmaceutical intermediate for clarithromycin

4-Oxazolidinecarboxylic acid, 3-((2S)-2-(((9H-fluoren-9-ylmethoxy)carbonyl)amino)-1-oxo-3-phenylpropyl)-2,2,5-trimethyl-, (4S,5R)-

Fmoc-protected amino acid building block